Status:
COMPLETED
Probiotics in the Treatment of Irritable Bowel Syndrome
Lead Sponsor:
Islamic Azad University, Najafabad Branch
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Some evidences have shown that probiotics are effective in the treatment of irritable bowel syndrome. Because few evidences are available in our population, we investigated if probiotics are effective...
Eligibility Criteria
Inclusion
- age between 18 and 65
- diagnosis of IBS based on the Rome III criteria
- willingness to participate
Exclusion
- receiving other probiotics compound during the study
- receiving antibiotics during the study
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT01837485
Start Date
August 1 2011
End Date
March 1 2013
Last Update
April 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shariati Hospital
Isfahan, Isfahan, Iran